NCT06069024View on ClinicalTrials.gov

Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Multiple MyelomaMyelodysplastic SyndromesLymphoma
Trial Locations (1)

Unknown

the First Affiliated Hospital of Shandong First Medical University, Jinan

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER

NCT06069024 - Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide | Biotech Hunter | Biotech Hunter